[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 158,393,936
  • Shares Outstanding, K 5,699,674
  • Annual Sales, $ 62,579 M
  • Annual Income, $ 7,771 M
  • EBIT $ 18,639 M
  • EBITDA $ 25,231 M
  • 60-Month Beta 0.34
  • Price/Sales 2.57
  • Price/Cash Flow 6.20
  • Price/Book 1.82

Options Overview Details

View History
  • Implied Volatility 22.44% (-1.03%)
  • Historical Volatility 21.23%
  • IV Percentile 20%
  • IV Rank 25.65%
  • IV High 34.15% on 10/10/25
  • IV Low 18.40% on 08/22/25
  • Expected Move (DTE 7) 0.63 (2.26%)
  • Put/Call Vol Ratio 0.57
  • Today's Volume 130,091
  • Volume Avg (30-Day) 122,935
  • Put/Call OI Ratio 0.82
  • Today's Open Interest 2,710,399
  • Open Int (30-Day) 2,538,310
  • Expected Range 27.16 to 28.42

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.79
  • Number of Estimates 6
  • High Estimate $0.94
  • Low Estimate $0.67
  • Prior Year $0.87
  • Growth Rate Est. (year over year) -9.20%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.44 +13.49%
on 07/27/26
28.43 -2.44%
on 08/19/26
+2.80 (+11.23%)
since 07/21/26
3-Month
23.62 +17.44%
on 07/06/26
28.43 -2.44%
on 08/19/26
+1.79 (+6.90%)
since 05/21/26
52-Week
23.58 +17.64%
on 09/25/25
28.75 -3.50%
on 04/02/26
+2.00 (+7.77%)
since 08/21/25

Most Recent Stories

More News
Why Pfizer (PFE) Stock Is Trading Up Today

Why Pfizer (PFE) Stock Is Trading Up Today

PFE : 27.74 (-0.18%)
Bull Call Spread Screener Results For August 19th

With stocks in bullish mode it’s a good time to run Barchart’s Bull Call Spread Screener.

NFLX : 80.13 (-0.01%)
NVDA : 218.13 (+0.59%)
CVS : 93.90 (+0.27%)
CVX : 205.80 (+0.01%)
XOM : 165.98 (-0.10%)
PFE : 27.74 (-0.18%)
2 Profitable Stocks with Solid Fundamentals and 1 We Ignore

2 Profitable Stocks with Solid Fundamentals and 1 We Ignore

PRIM : 79.00 (-0.30%)
BTSG : 59.90 (+0.62%)
PFE : 27.74 (-0.18%)
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Submission based on favorable efficacy and safety results from Phase 3 VALOR trial

VALN : 6.82 (-0.29%)
PFE : 27.74 (-0.18%)
5 Insightful Analyst Questions From Pfizer’s Q2 Earnings Call

5 Insightful Analyst Questions From Pfizer’s Q2 Earnings Call

PFE : 27.74 (-0.18%)
3 High-Yield Dividend ETFs Paying Up to 7.8%

Diversify your holdings while generating several times more income than the broader market with these three high-yield ETFs.

CVX : 205.80 (+0.01%)
VZ : 49.08 (-0.22%)
TTE : 91.11 (+0.23%)
WES : 48.73 (+0.16%)
ENLAY : 11.0400 (+0.09%)
MPLX : 58.67 (+0.12%)
AMZA : 49.79 (-0.02%)
SUN : 75.70 (+0.38%)
PFE : 27.74 (-0.18%)
FDL : 53.08 (-0.69%)
ET : 21.28 (+0.33%)
PAA : 24.70 (+0.45%)
MRNA Stock Gets a Shot in the Arm as FDA Approves Moderna Flu Vaccine

Moderna has secured FDA approval for its flu vaccine mFLUSIVA. But does that warrant buying MRNA shares today? Let’s find out!

AZN : 164.33 (-0.10%)
MRNA : 134.44 (+0.84%)
RHHBY : 57.2500 (-1.63%)
PFE : 27.74 (-0.18%)
PFE Q2 Deep Dive: New Products Offset COVID Decline, R&D Pipeline Expands

PFE Q2 Deep Dive: New Products Offset COVID Decline, R&D Pipeline Expands

PFE : 27.74 (-0.18%)
Pfizer’s (NYSE:PFE) Q2 CY2026: Beats On Revenue

Pfizer’s (NYSE:PFE) Q2 CY2026: Beats On Revenue

PFE : 27.74 (-0.18%)
Pfizer: Q2 Earnings Snapshot

Pfizer: Q2 Earnings Snapshot

PFE : 27.74 (-0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 28.60
2nd Resistance Point 28.38
1st Resistance Point 28.09
Last Price 27.74
1st Support Level 27.57
2nd Support Level 27.35
3rd Support Level 27.06

See More

52-Week High 28.75
Last Price 27.74
Fibonacci 61.8% 26.77
Fibonacci 50% 26.16
Fibonacci 38.2% 25.55
52-Week Low 23.58

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.